` ME (23andMe Holding Co.) vs S&P 500 Comparison - Alpha Spread

ME
vs
S&P 500

Over the past 12 months, ME has underperformed S&P 500, delivering a return of -93% compared to the S&P 500's +13% growth.

Stocks Performance
ME vs S&P 500

Loading
ME
S&P 500
Add Stock

Performance Gap
ME vs S&P 500

Loading
ME
S&P 500
Difference
www.alphaspread.com

Performance By Year
ME vs S&P 500

Loading
ME
S&P 500
Add Stock

Competitors Performance
23andMe Holding Co. vs Peers

23andMe Holding Co.
Glance View

Market Cap
88.5m USD
Industry
Health Care

23andMe Holding Co. is consumer genetics and research company, which engages to help people access, understand, and benefit from the human genome. The company is headquartered in South San Francisco, California. The company went IPO on 2020-10-06. The firm offers direct-to-consumer genetic testing and personalized information about genetic health risks, ancestry, and traits. The firm operates through two segments: Consumer & Research Services and Therapeutics. Its consumer & research services business segment comprises personal genome service (PGS) and research services. Its PGS provides a suite of genetic reports, including information on genetic ancestral origins, personal genetic health risks, rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications. The Company’s therapeutics segment focuses on drug development for discovering and developing therapies to improve patient lives and includes out-licensing of intellectual property. The Company’s programs across therapeutic areas, include oncology, immunology, neurology, metabolic and cardiovascular diseases.

ME Intrinsic Value
5.6549 USD
Undervaluation 89%
Intrinsic Value
Price
Back to Top